KYMERA THERAPEUTICS INC's ticker is KYMR and the CUSIP is 501575104. A total of 53 filers reported holding KYMERA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $1,042 | +56.7% | 25,917 | -0.7% | 0.01% | +50.0% |
| Q4 2023 | $665 | +83.2% | 26,109 | 0.0% | 0.01% | +50.0% |
| Q3 2023 | $363 | -39.5% | 26,109 | 0.0% | 0.00% | -33.3% |
| Q2 2023 | $600 | -22.5% | 26,109 | 0.0% | 0.01% | -25.0% |
| Q1 2023 | $774 | +35.3% | 26,109 | +14.0% | 0.01% | +33.3% |
| Q4 2022 | $572 | -99.9% | 22,910 | -25.7% | 0.01% | -25.0% |
| Q3 2022 | $671,000 | +22.0% | 30,838 | +137.2% | 0.01% | +60.0% |
| Q1 2022 | $550,000 | -33.3% | 13,000 | 0.0% | 0.01% | -28.6% |
| Q4 2021 | $825,000 | +8.0% | 13,000 | 0.0% | 0.01% | 0.0% |
| Q3 2021 | $764,000 | +21.1% | 13,000 | 0.0% | 0.01% | +16.7% |
| Q2 2021 | $631,000 | +25.0% | 13,000 | 0.0% | 0.01% | +20.0% |
| Q1 2021 | $505,000 | -37.3% | 13,000 | 0.0% | 0.01% | -37.5% |
| Q4 2020 | $806,000 | +91.9% | 13,000 | 0.0% | 0.01% | +60.0% |
| Q3 2020 | $420,000 | – | 13,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 5,350,422 | $159,710,097 | 16.82% |
| Aquilo Capital Management, LLC | 328,743 | $9,812,979 | 9.46% |
| BVF INC/IL | 5,161,801 | $154,079,760 | 4.32% |
| Redmile Group, LLC | 1,579,275 | $47,141,359 | 2.85% |
| Deer Management Co. LLC | 415,895 | $12,414,466 | 2.55% |
| Artal Group S.A. | 3,005,610 | $89,717,459 | 2.29% |
| Baker Brothers Advisors | 5,995,928 | $178,978,451 | 2.29% |
| Avoro Capital Advisors LLC | 3,888,888 | $116,083,307 | 1.55% |
| Checkpoint Capital L.P. | 82,000 | $2,447,700 | 1.48% |
| Deep Track Capital, LP | 1,500,000 | $44,775,000 | 1.34% |